IQST vs TECH · rev $316.9M vs P/E 65, rev $1.22B
Iqstel Inc (IQST) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Iqstel Inc (IQST) is a telecom services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported IQST revenue for 2025-12-31 was $316.9M. Net income was -$8.5M. Revenue was up 11.9% from 2024-12-31 to 2025-12-31. IQST currently screens at market cap $6.5M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
IQST currently screens at market cap $6.5M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the IQST and TECH stock pages for the full models.
Not investment advice.